Section one: Contracting authority
one.1) Name and addresses
NHS DEVON INTEGRATED CARE BOARD
Aperture House, Pynes Hill, Rydon Lane,
Exeter
EX25AZ
Contact
Tracey Kerslake
Telephone
+44 1392205205
Country
United Kingdom
Region code
UKK4 - Devon
NHS Organisation Data Service
QJK
Internet address(es)
Main address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Antipsychotic Medication Reviews
Reference number
QJK-24_APMR
two.1.2) Main CPV code
- 85121270 - Psychiatrist or psychologist services
two.1.3) Type of contract
Services
two.1.4) Short description
Provision of an antipsychotic prescribing and drug safety monitoring service for patients registered with a GP in Devon
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £0.01
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKK4 - Devon
two.2.4) Description of the procurement
The primary aim of this service is to provide ongoing prescribing of antipsychotic medications and drug safety monitoring for patients across NHS Devon with an initial requirement for up to 120 patients. The provider will:
• Ensure ongoing drug safety monitoring and prescribing including appropriate blood tests and ECGs and informed by NICE guidelines
• Ensure that any concerns related to the person's mental health are appropriately escalated to the secondary mental health provider.
• Issue prescription that will be dispended by the patient's local pharmacy.
It is anticipated that after an initial review, 1-2 months prescription lengths would be required, with a 12 month annual review. However, the provider must use clinical judgement, informed by NICE guidance, to determine the physical health monitoring needs of the individual and safe length of prescription.
The ICB envisages care being delivered as close to home as possible, however this could include the service being delivered remotely, with the preferred remote method of contact being agreed with the patient. Where the service is delivered remotely it is anticipated that the primary method will be via Teams (or an equivalent system for safe virtual delivery) and the provider will take reasonable steps to support the patient in the utilisation of IT where advice and guidance may be required e.g. easy to read, jargon free instructions. Should digital poverty or IT connectivity prevent use of virtual delivery, the provider needs to have mitigations available.
This notice is an intention to award a contract under the Provider Selection Regime Most Suitable Provider process.
This is a new service and the award is to an existing contracted provider
The contract term is for a period 12 months. The cost of the service will be based on activity with an anticipated annual cost of approximately £945 per patient where a face to face consultation is required and £645 per patient where a virtual consultation is undertaken. There maybe additional costs payable for diagnostic tests
two.2.5) Award criteria
Quality criterion - Name: Most suitable provider process with regard to the key criteria / Weighting: 80
Cost criterion - Name: Most suitable provider process with regard to price / Weighting: 20
two.2.11) Information about options
Options: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The publication of this notice marks the start of the standstill period.
Representations by providers must be made to the relevant authority by 23 October 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.'
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
Section five. Award of contract
Contract No
QJK-25_APMR
Title
Antipsychotic Medication Reviews
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
13 October 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
RTN Medical Limited
167-169 Great Portland Street, 5th Floor,
Londong
W1W 5PF
Country
United Kingdom
NUTS code
- UKI - London
Companies House
14100590
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £0.01
Total value of the contract/lot: £0.01
Section six. Complementary information
six.3) Additional information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 23 October 2025. This contract has not yet been formally awarded; this notice serves as an intention to award under PSR.
Notices previously published on Find A Tender in relation to this award:
2025/S 000-052253 29 August 2025
2025/S 000-047397 08 August 2025
six.4) Procedures for review
six.4.1) Review body
NHS Devon ICB
Aperture House, Pynes Hill, Rydon Lane,
Exeter
EX2 5AZ
Country
United Kingdom